XML 68 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Net sales $ 1,820,678 $ 1,486,998 $ 881,591
Cost of sales 1,526,539 1,254,890 777,501
Gross profit 294,139 232,108 104,090
Selling, general & administrative expenses 126,157 85,917 57,565
Research and development expenses 7,148 4,228 6,317
Royalty expense 12,260 9,790 9,263
Supply agreement termination income (26,134) 0 0
Income from operations 174,708 132,173 30,945
Interest expense (27,658) (25,259) (26,667)
Noncash convertible debt conversion charge 0 (16,135) 0
Loss on senior note repurchase 0 0 (14,573)
Noncash Titan Europe Plc gain 26,700 0 0
Other income (expense) 6,823 5,116 1,105
Income before income taxes 180,573 95,895 (9,190)
Provision (benefit) for income taxes 86,613 37,759 (3,264)
Net income (loss) 93,960 58,136 (5,926)
Net loss attributable to noncontrolling interests (1,593) (16) 0
Net income (loss) attributable to Titan $ 95,553 $ 58,152 $ (5,926) [1]
Earnings per common share:      
Basic (in dollars per share) $ 2.20 [2] $ 1.40 [2] $ (0.17)
Diluted (in dollars per share) $ 1.83 [2] $ 1.18 [1],[2] $ (0.17)
Average common shares outstanding:      
Basic (in shares) 43,380 41,657 34,896
Diluted (in shares) 54,662 53,144 [1] 34,896
Dividends declared per common share: $ 0.02 $ 0.02 $ 0.02
[1] The effect of stock options/trusts has been excluded as they were anti-dilutive. The weighted-average share amount excluded for stock options/trusts totaled 495,789 shares. The effect of convertible notes has not been included as they were anti-dilutive. The weighted-average share amount excluded for convertible notes totaled 16,764,701 shares.
[2] As a result of changes in outstanding share balances and dilution factors, year-end per share amounts do not agree to the sum of the quarters.